Synonym:Eptifibatide;148031-34-9;Somatostatin;Eptifibatide Acetate;INTEGRELIN;Human Eptifibatide;Eptifitide;EFTIFIBATIDE;
Description:Eptifibatide is a platelet glycoprotein receptor reversible antagonist,adverse reactions are mild , it can be discontinued immediately while adverse reactions occur . It has Strong effect and high selectivity . It has no antigenicity,and it does not cause allergic reactions. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events. It can limit the non-Q-wave myocardial infarction,and reduce through wall myocardial infarction occurrance.
Eptifibatide is used to treat acute coronary syndrome, the starting amount is 180ug/kg, the intravenous maintenance dose is per minute 2ug/kg continuous intravenous infusion 72h, if implementing the primary percutaneous coronary intervention, continuous intravenous drip after surgery is 18-24h. For percutaneous coronary intervention, the starting amount is 180ug/kg intravenous injection, after 2ug/kg continuous intravenous infusion every minute, after 10 min, administrated again with 180ug/kg intravenously per minute , thereafter 2ug/kg continuous intravenous infusion for 18-24h.